Back to top of page

Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

- Name of the applicant (individual, institution, or business)

- Description of the therapeutic or diagnostic device being developed

- Description of the disorder affecting the nervous or neuromuscular systems being targeted

- Plan for implementation of clinical prototype devices

- Plan for non-clinical safety and efficacy testing

- Plan for design verification and validation activities

- Plan for obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study

- Plan for conducting a subsequent clinical feasibility study

- Justification for the need to conduct a clinical study to obtain information that cannot be obtained through non-clinical assessments

- Milestones for the project

- Funding requirements for all activities to be conducted in the applicant's own laboratories

- Potential areas of collaboration with NIH-funded consultants for regulatory, reimbursement, intellectual property, commercialization, and strategic partnerships

- Potential collaboration with NIH contract research organizations for large animal testing, sterilization testing, biocompatibility assessment, manufacturing, and medical monitoring

- Evidence of existing collaborations with device manufacturers (if applicable)

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows